(HealthDay News) — More than one in five young adults report using cannabis or alcohol to get to sleep, according to a research letter published online Oct. 13 in JAMA Pediatrics.

Smaller declines seen in early-stage cancer diagnosis during COVID-19 pandemic in adults aged 18 to 44 years, men, those with high comorbidity burden.

The phase 3 POTOMAC trial tested durvalumab added to BCG in patients with high-risk non-muscle-invasive bladder cancer (NMIBC).

Adding durvalumab to induction and maintenance with Bacillus Calmette–Guérin (BCG) can improve disease-free survival in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer, data ...

Prevalence increased to 68.6 percent with new criteria, which include anthropometric measures such as waist circumference, waist-to-hip ratio, waist-to-height ratio.

Immune checkpoint inhibitors have shown efficacy in other HPV-related cancers, so a phase 2 trial tested avelumab treatment for locally advanced or metastatic penile cancer.

Adding EV and pembrolizumab to surgical treatment can improve outcomes in MIBC patients who are ineligible for cisplatin, data suggest.

The researchers found that compared with those without GERD, patients with GERD had a 27 percent increased risk for incident AMI (pooled relative risk, 1.27). No significant publication bias was seen ...

Investigators presented initial results from a phase 3 trial of adjuvant durvalumab plus tremelimumab for resected primary renal cell carcinoma (RCC).

First-line treatment with disitamab vedotin and toripalimab improved outcomes over chemotherapy in patients with HER2-expressing, locally advanced or metastatic urothelial carcinoma.

Studies show patients with chronic kidney disease (CKD) and COVID-19 are at increased risk for an intensive care unit stay and early death. Anemia is an extra risk factor.

Nearly 700 medicines used in the U.S. to treat common conditions contain at least one chemical sourced only in China.